Postby mpbser » Fri May 10, 2019 8:32 am
I finally had a chance to look at those links on Xeloda increasing MCV and its predictive value. Does this mean that if MCV stays the same, completely in the middle of the normal range, that the chemo (currently folfiri in my husband's case) may be at an adequate dosage or otherwise "isn't working"? From those articles, it seems that the higher the MCV, the better, during chemo. Always something to be worried about.......!
Wife 4/17 Dx age 45
5/17 LAR
Adenocarcinoma
low grade
1st primary T3 N2b M1a
Stage IVA
8/17 Sub-total colectomy
2nd primary 5.5 cm T1 N0
9 of 96 nodes
CEA: < 2.9
MSS
Lynch no; KRAS wild
Immunohistochemsistry Normal
Fall 2017 FOLFOX shrank the 1 met in liver
1/18 Liver left hepatectomy seg 4
5/18 CT clear
12/18 MRI 1 liver met
3/7/19 Resection & HAI
4/1/19 Folfiri & FUDR
5/13/19 HAI pump catheter dislodge, nearly bled to death
6-7 '19 5FU 4 cycles
NED